Strong performance by Nolato Medical and proposed increase in dividend
Today’s 2016 year-end report from Nolato posts strong performance by Nolato Medical, with currency-adjusted organic growth of 11% and a high operating margin of 13.1%. · Sales totalled SEK 4,447 million (4,726) · Operating profit (EBITA) was SEK 457 million (570) · The operating margin (EBITA) was 10.3% (12.1) · Earnings per share were SEK 12.77 (15.97) · The equity/assets ratio was 47% (54), with a net financial liability of SEK 408 million (+122, net asset) · The Board of Directors proposes an increase in the dividend to SEK 10.50 (10.00) per share Nolato Medical’s